- Jun 3, 2019
Aravax Presents Additional Positive PVX108 Phase 1 Clinical Trial Safety Results at EAACI 2019
June 4, 2019, Melbourne, Victoria –Trial results demonstrate excellent PVX108 safety profile in patients with prior anaphylaxis and...
top of page
Developing safe, convenient, disease-modifying treatments for food allergies.
.jpg)
News
bottom of page